CN107259318A - 一种营养保健食品 - Google Patents
一种营养保健食品 Download PDFInfo
- Publication number
- CN107259318A CN107259318A CN201710455389.2A CN201710455389A CN107259318A CN 107259318 A CN107259318 A CN 107259318A CN 201710455389 A CN201710455389 A CN 201710455389A CN 107259318 A CN107259318 A CN 107259318A
- Authority
- CN
- China
- Prior art keywords
- powder
- buckwheat
- edible
- health food
- black
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 22
- 235000013402 health food Nutrition 0.000 title claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 56
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 26
- 241000371652 Curvularia clavata Species 0.000 claims abstract description 20
- 244000000626 Daucus carota Species 0.000 claims abstract description 17
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 13
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 12
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 12
- 235000021279 black bean Nutrition 0.000 claims abstract description 12
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 12
- 235000013312 flour Nutrition 0.000 claims abstract description 12
- 235000012054 meals Nutrition 0.000 claims abstract description 12
- 235000013336 milk Nutrition 0.000 claims abstract description 12
- 239000008267 milk Substances 0.000 claims abstract description 12
- 210000004080 milk Anatomy 0.000 claims abstract description 12
- 235000020234 walnut Nutrition 0.000 claims abstract description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 10
- 239000011780 sodium chloride Substances 0.000 claims abstract description 10
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 7
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract 4
- 240000007049 Juglans regia Species 0.000 claims abstract 4
- 239000000835 fiber Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 11
- 235000013339 cereals Nutrition 0.000 abstract description 6
- 230000007774 longterm Effects 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 238000009835 boiling Methods 0.000 abstract description 3
- 238000009472 formulation Methods 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 3
- 235000021395 porridge Nutrition 0.000 abstract description 3
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 241000219051 Fagopyrum Species 0.000 description 19
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 241000723347 Cinnamomum Species 0.000 description 8
- 241000758789 Juglans Species 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 241000522254 Cassia Species 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 2
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010018473 Glycosuria Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108700000434 Cannabis sativa edestin Proteins 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 108010069201 VLDL Cholesterol Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- -1 and carrotene Chemical compound 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- FFIAPLNALYDYQK-UHFFFAOYSA-L barium(2+);[2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl phosphate Chemical compound [Ba+2].OCC1OC(O)(COP([O-])([O-])=O)C(O)C1O FFIAPLNALYDYQK-UHFFFAOYSA-L 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种营养保健食品，按照重量份的原料包括：食用海盐0.2‑0.4g、火麻蛋白粉4‑6g、核桃粉2‑4g、荞麦粉2.5‑3.5g、黑米粉2.5‑3.5g、黑豆粉9‑13g、燕麦粉1.5‑2.5g、奶粉0.8‑1.2g、胡萝卜粉2.5‑3.5g、肉桂粉0.1‑0.3g。本发明配方中的粉状物用小袋包装，用开水冲调，每天食用早晚各一袋，长期服用可对糖尿病、三高的人群有一定的改善功能，且本发明纯粮绿色配方，对人体无任何副作用，适用于中老年等各类群体，普通人冲调，可作为营养粥食用。
Description
技术领域
本发明涉及一种营养保健食品，具体是一种适用于患有糖尿病及三高病人的营养保健食品。
背景技术
糖尿病是由遗传因素、免疫功能紊乱、微生物感染及其毒素、自由基毒素、精神因素等等各种致病因子作用于机体导致胰岛功能减退而引发的糖、蛋白质、脂肪、水和电解质等一系列代谢紊乱综合症，临床上以高血糖为主要特点，典型病例可出现多尿、多饮、多食、消瘦等表现，即“三多一少”的症状。糖尿病是一种血液中的葡萄糖容易堆积过多的疾病。国外给它的别名叫“沉默的杀手”，特别是“成人型糖尿病”，四十岁以上的中年人染患率特别高，在日本，四十岁以上的人口中占100，即十人当中就有一位糖尿病患者。一旦患上糖尿病，将减少寿命十年之多，且可能发生的并发症遍及全身。
糖尿病人的日常饮食有很多禁忌，因此开发研究适合糖尿病人食用的保健食品已经成为医学界和食品研究机构的研究热点之一。
发明内容
本发明的目的在于提供一种可以降低血糖、无副作用的营养保健食品，以解决上述背景技术中提出的问题。
为实现上述目的，本发明提供如下技术方案：
一种营养保健食品，按照重量份的原料包括：食用海盐0.2-0.4g、火麻蛋白粉4-6g、核桃粉2-4g、荞麦粉2.5-3.5g、黑米粉2.5-3.5g、黑豆粉9-13g、燕麦粉1.5-2.5g、奶粉0.8-1.2g、胡萝卜粉2.5-3.5g、肉桂粉0.1-0.3g。
作为本发明进一步的方案：
所述营养保健食品，按照重量份的原料包括：食用海盐0.25-0.35g、火麻蛋白粉4.5-5.5g、核桃粉2.5-3.5g、荞麦粉2.8-3.2g、黑米粉2.8-3.2g、黑豆粉10-12g、燕麦粉1.8-2.2g、奶粉0.9-1.1g、胡萝卜粉2.8-3.2g、肉桂粉0.15-0.25g。
作为本发明再进一步的方案：
所述营养保健食品，按照重量份的原料包括：食用海盐0.3g、火麻蛋白粉5g、核桃粉3g、荞麦粉3g、黑米粉3g、黑豆粉11g、燕麦粉2g、奶粉1g、胡萝卜粉3g、肉桂粉0.2g。
下面对相关原料的药食特性进行简单介绍：
火麻蛋白粉：火麻蛋白被誉为植物王国里最杰出的蛋白质，约有2/3的麻仁球蛋白和1/3的白蛋白，非常容易被人体消化和吸收，可用作消化疾病患者的食物。富含8种人体所需要的必需氨基酸，多种脂肪酸、蛋白质、纤维素、矿物质等营养物质。
核桃：含有丰富的营养素，每百克含蛋白质15-20克，脂肪较多，碳水化合物10克；并含有人体必需的钙、磷、铁等多种微量元素和矿物质，以及胡萝卜素、核黄素等多种维生素。对人体有益。
核桃味甘、性平，温，无毒，微苦，微涩；入肾、肺、大肠经，可补肾、固精强腰、温肺定喘、润肠通便。每周坚持食用5次坚果的女性患2型糖尿病的风险减少近30％，坚果中的不饱和脂肪有益于胰岛素分解。
荞麦：荞麦的谷蛋白含量很低，主要的蛋白质是球蛋白。荞麦所含的必需氨基酸中的赖氨酸含量高而蛋氨酸的含量低，氨基酸模式可以与主要的谷物(如小麦、玉米、大米的赖氨酸含量较低)互补；荞麦的碳水化合物主要是淀粉。因为颗粒较细小，所以和其他谷类相比，具有容易煮熟、容易消化、容易加工的特点；荞麦含有丰富的膳食纤维，其含量是一般精制大米的10倍；荞麦含有的铁、锰、锌等微量元素也比一般谷物丰富。
荞麦的降压作用：以含荞麦粉的饲料饲养大鼠4星期，血压有轻度下降。荞麦对血管紧张素转化酶(ACE)有强大抑制作用，其有效成分可能是耐热的低分子物质。从荞麦种子核心部分提取的一种三肽，对ACE的IC50为12.7μmol/L，实验表明对自发性高血压大鼠(SHR)有抗高血压作用。
荞麦对血脂和血糖的影响：志愿者吃荞麦粉4星期，使高密度脂蛋白-胆固醇/总胆固醇的比值明显增加，极低密度脂蛋白-胆固醇、极低密度脂蛋白-三酸甘油、低密度脂蛋白-三酰甘油和高密度脂蛋白-三酰甘油明显降低，并使血糖降低，口服葡萄糖的耐受能力改善。以含荞麦粉的饲料饲养4星期的大鼠，对葡萄糖的耐受能力也提高，并在葡萄糖负荷后1h，胰岛素的利用速度加快。高脂饮食兔服用荞麦提取物12星期后，可轻微降低血中丙二醛(MDA)浓度，但显着增加肝中抗坏血酸自由基的含量并伴随血中β-脂蛋白水平和肝中胆固醇和三酰甘油浓度的降低，血中苯乙酸***也同时增加，作用远远强于芸香甙。
黑米：中医认为黑米有显著的药用价值，古农医书记载：黑米“滋阴补肾，健身暖胃，明目活血”，“清肝润肠”，“滑湿益精，补肺缓筋”等功效；可入药入膳，对头昏目眩、贫血白发、腰膝酸软、夜盲耳鸣症、疗效尤佳。长期食用可延年益寿。现代医学证实，黑米具有滋阴补肾，健脾暖肝、补益脾胃，益气活血，养肝明目等疗效。经常食用黑米，有利于防治头昏、目眩、贫血、白发、眼疾、腰膝酸软、肺燥咳嗽、大便秘结、小便不利、肾虚水肿、食欲不振、脾胃虚弱等症。黑米所含锰、锌、铜等无机盐大都比大米高1-3倍；更含有大米所缺乏的维生素C、叶绿素、花青素、胡萝卜素及强心甙等特殊成分，因而黑米比普通大米更具营养。多食黑米具有开胃益中，健脾暖肝，明目活血，滑涩补精之功，对于少年白发、妇女产后虚弱，病后体虚以及贫血、肾虚均有很好的补养作用。
黑豆：黑豆性平、味甘；归脾、肾经；具有消肿下气、润肺燥热、活血利水、祛风除痹、补血安神、明目健脾、补肾益阴、解毒的作用；用于水肿胀满、风毒脚气、黄疸浮肿、风痹痉挛、产后风疼、口噤、痈肿疮毒，可解药毒，制风热而止盗汗，乌发黑发以及延年益寿的功能。
燕麦：燕麦中的B族维生素、尼克酸、叶酸、泛酸都比较丰富，特别是维生素E，每100克燕麦粉中高达15毫克。此外燕麦粉中还含有谷类食粮中均缺少的皂甙(人参的主要成分)。蛋白质的氨基酸组成比较全面，人体必需的8种氨基酸含量的均居首位，尤其是含赖氨酸高达0.68克。麦中的β-葡聚糖可减缓血液中葡萄糖含量的增加，预防和控制肥胖症、糖尿病及心血管疾病。燕麦富含的膳食纤维具有清理肠道垃圾的作用，燕麦降低血压、降低胆固醇、防治大肠癌、防治心脏疾病的医疗价值和保健作用，已被古今中外医学界所公认。
胡萝卜：胡萝卜素中含的槲皮素、山柰酚能增加冠状动脉血流量，降低血脂，促进肾上腺素的合成，因而有降压强心的作用。胡萝卜中含有琥珀酸钾盐，有助于防止血管硬化，降低胆固醇及有降低血压的作用。胡萝卜中的叶酸，能减少冠心病发病因素。高血压者饮胡萝卜汁后，有很好的降压作用。吃较多胡萝卜的人群，比吃较少胡萝卜的人群，心脏病例几乎减少50％。
肉桂：[营养成分]肉桂味辛、甘、大热。辛热散寒、甘热助阳、温通行滞、作用温和持久，官运亨通而不走。有补火助阳、散寒止痛、温通血脉的功效，运用于肾阳不足、均可起到温补的效果。
[药用功效]近10年国内钻研究文献报道，中药肉桂单方及复方具有降低血糖和调解血脂的作用。浙江中医药大学何岚教授通过小白鼠和临床作用，并建议人们在每天的饮食中适当加入含有肉桂的香料，同时可以粉碎为细粉，每日口服。
中药肉桂治疗糖尿病作用己通过临床实践及现代药理研究证明，明确降血糖、降血脂，稳定血糖、血脂水平，长期维持糖化血红蛋白的正常水平作用。肉桂对防治糖尿病及其并发症状、体征、提高患者的生活质量，还是改善血糖、糖化血红蛋白、血脂、血载、蛋白尿方面都起到较好的作用。
与现有技术相比，本发明的有益效果是：
本发明配方中的粉状物用小袋包装，用开水冲调，每天食用早晚各一袋，长期服用可对糖尿病、三高的人群有一定的改善功能，且本发明纯粮绿色配方，对人体无任何副作用，适用于中老年等各类群体，普通人冲调，可作为营养粥食用。
具体实施方式
下面结合具体实施方式对本专利的技术方案作进一步详细地说明。
实施例1
一种营养保健食品，按照重量份的原料包括：食用海盐0.2g、火麻蛋白粉4g、核桃粉2g、荞麦粉2.5g、黑米粉2.5g、黑豆粉9g、燕麦粉1.5g、奶粉0.8g、胡萝卜粉2.5g、肉桂粉0.1g。
实施例2
一种营养保健食品，按照重量份的原料包括：食用海盐0.25g、火麻蛋白粉4.5g、核桃粉2.5g、荞麦粉2.8g、黑米粉2.8g、黑豆粉10g、燕麦粉1.8g、奶粉0.9g、胡萝卜粉2.8g、肉桂粉0.15g。
实施例3
一种营养保健食品，按照重量份的原料包括：食用海盐0.3g、火麻蛋白粉5g、核桃粉3g、荞麦粉3g、黑米粉3g、黑豆粉11g、燕麦粉2g、奶粉1g、胡萝卜粉3g、肉桂粉0.2g。
实施例4
一种营养保健食品，按照重量份的原料包括：食用海盐0.35g、火麻蛋白粉5.5g、核桃粉3.5g、荞麦粉3.2g、黑米粉3.2g、黑豆粉12g、燕麦粉2.2g、奶粉1.1g、胡萝卜粉3.2g、肉桂粉0.25g。
实施例5
一种营养保健食品，按照重量份的原料包括：食用海盐0.4g、火麻蛋白粉6g、核桃粉4g、荞麦粉3.5g、黑米粉3.5g、黑豆粉13g、燕麦粉2.5g、奶粉1.2g、胡萝卜粉3.5g、肉桂粉0.3g。
本发明配方中的粉状物用小袋包装，用开水冲调，每天食用早晚各一袋，长期服用可对糖尿病、三高的人群有一定的改善功能，且本发明纯粮绿色配方，对人体无任何副作用，适用于中老年等各类群体，普通人冲调，可作为营养粥食用。
上面对本专利的较佳实施方式作了详细说明，但是本专利并不限于上述实施方式，在本领域的普通技术人员所具备的知识范围内，还可以在不脱离本专利宗旨的前提下作出各种变化。
Claims (3)
1.一种营养保健食品，其特征在于，按照重量份的原料包括：食用海盐0.2-0.4g、火麻蛋白粉4-6g、核桃粉2-4g、荞麦粉2.5-3.5g、黑米粉2.5-3.5g、黑豆粉9-13g、燕麦粉1.5-2.5g、奶粉0.8-1.2g、胡萝卜粉2.5-3.5g、肉桂粉0.1-0.3g。
2.根据权利要求1所述的营养保健食品，其特征在于，按照重量份的原料包括：食用海盐0.25-0.35g、火麻蛋白粉4.5-5.5g、核桃粉2.5-3.5g、荞麦粉2.8-3.2g、黑米粉2.8-3.2g、黑豆粉10-12g、燕麦粉1.8-2.2g、奶粉0.9-1.1g、胡萝卜粉2.8-3.2g、肉桂粉0.15-0.25g。
3.根据权利要求1所述的营养保健食品，其特征在于，按照重量份的原料包括：食用海盐0.3g、火麻蛋白粉5g、核桃粉3g、荞麦粉3g、黑米粉3g、黑豆粉11g、燕麦粉2g、奶粉1g、胡萝卜粉3g、肉桂粉0.2g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710455389.2A CN107259318A (zh) | 2017-06-16 | 2017-06-16 | 一种营养保健食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710455389.2A CN107259318A (zh) | 2017-06-16 | 2017-06-16 | 一种营养保健食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107259318A true CN107259318A (zh) | 2017-10-20 |
Family
ID=60067239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710455389.2A Pending CN107259318A (zh) | 2017-06-16 | 2017-06-16 | 一种营养保健食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107259318A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107950666A (zh) * | 2017-12-26 | 2018-04-24 | 吉林市永鹏农副产品开发有限公司 | 一种预防骨质疏松的营养米粉及其制备方法 |
| EP3986164A4 (en) * | 2019-06-18 | 2023-07-19 | Gamble, Mardelle | NUTRITIONAL COMPOSITIONS |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101057639A (zh) * | 2007-05-20 | 2007-10-24 | 山西金绿禾燕麦研究所 | 燕麦杂粮方便米饭 |
| CN103652567A (zh) * | 2012-09-20 | 2014-03-26 | 劲家庄(惠州)健康食品有限公司 | 什锦全谷物功能营养方便食品 |
| CN104431741A (zh) * | 2015-01-14 | 2015-03-25 | 张桂英 | 一种谷物调理粥及其制备方法和用途 |
| CN104642893A (zh) * | 2015-02-02 | 2015-05-27 | 广西贵港市港九粮食制品有限公司 | 火麻营养米粉的制备方法 |
-
2017
- 2017-06-16 CN CN201710455389.2A patent/CN107259318A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101057639A (zh) * | 2007-05-20 | 2007-10-24 | 山西金绿禾燕麦研究所 | 燕麦杂粮方便米饭 |
| CN103652567A (zh) * | 2012-09-20 | 2014-03-26 | 劲家庄(惠州)健康食品有限公司 | 什锦全谷物功能营养方便食品 |
| CN104431741A (zh) * | 2015-01-14 | 2015-03-25 | 张桂英 | 一种谷物调理粥及其制备方法和用途 |
| CN104642893A (zh) * | 2015-02-02 | 2015-05-27 | 广西贵港市港九粮食制品有限公司 | 火麻营养米粉的制备方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107950666A (zh) * | 2017-12-26 | 2018-04-24 | 吉林市永鹏农副产品开发有限公司 | 一种预防骨质疏松的营养米粉及其制备方法 |
| EP3986164A4 (en) * | 2019-06-18 | 2023-07-19 | Gamble, Mardelle | NUTRITIONAL COMPOSITIONS |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103229963B (zh) | 一种经发芽处理的杂粮食品及其制备方法 | |
| CN102224891B (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
| CN105995995A (zh) | 一种多口味彩虹燕麦代餐粉及其制备方法 | |
| CN102113648A (zh) | 一种适合“五高”代谢综合症人群的特膳面条及其制备方法 | |
| CN103999996A (zh) | 一种保健板栗及其制备方法 | |
| CN102813120B (zh) | 海参防癌降糖面粉及制备方法 | |
| CN103211162A (zh) | 一种经发酵处理的杂粮食品及其制备方法 | |
| CN108719984B (zh) | 一种针对痛风人群的代餐营养棒及其制备方法 | |
| CN106107463A (zh) | 超级藜麦抗疲劳奶茶制作工艺 | |
| CN109007856A (zh) | 一种适合高血压、高血脂、高血糖和高尿酸人群服用的代餐粉及制备方法 | |
| CN105533415A (zh) | 一种高丽红参小麦胚芽抗氧化功能食品的制备方法 | |
| CN108391785A (zh) | 一种功能性代餐粉及其制作工艺与应用 | |
| CN108244633A (zh) | 一种祛湿健脾的保健食品组合物及其制备方法 | |
| CN105495414A (zh) | 一种高丽红参芝麻抗衰老功能食品的制备方法 | |
| CN102113652A (zh) | 一种适合“五高”代谢综合症人群的特膳挤压米及其制备方法 | |
| CN108991078A (zh) | 一种防控富贵病的桑叶食品及其制备方法 | |
| CN104738640A (zh) | 一种高丽红参膳食纤维大豆蛋白膨化粉的制备方法 | |
| CN107259318A (zh) | 一种营养保健食品 | |
| CN107095297A (zh) | 一种营养保健食品 | |
| CN109123614A (zh) | 一种适合于航天员食用的黑色营养餐制剂 | |
| CN103960426A (zh) | 一种中药减肥茶 | |
| CN110638038A (zh) | 一种用于控制高血糖的医学配方营养代餐粉及其制备方法 | |
| CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
| CN105166653A (zh) | 一种健胃养生红薯粥产品及其制作方法 | |
| CN108013459A (zh) | 一种具有减肥美容功能的保健食品及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171020 |